RxDoctor Payments Data

Joseph Atkin, MD

Family Medicine · Draper, UTNPI 1932428232

Payments from drug & device makers

$6,630in general payments, 2019–2025

Across 390 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$450
  • Novo Nordisk$409
  • GSK$363
  • Viiv Healthcare Company$293
  • Gilead$219
  • plus $3K from 51 others

What the payments were for

  • Food & beverage$6,630100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,630 in reported general payments places this provider in the 85th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$34,442
Medicare patients
97
Services billed
742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$29,577
OzempicSemaglutide13$23,659
JardianceEmpagliflozin15$22,378
TrulicityDulaglutide15$18,121
Celecoxib52$2,127
PaxlovidNirmatrelvir/Ritonavir17$1,429
Zolpidem Tartrate72$900
Tamsulosin Hcl56$855
Famotidine35$825
Levothyroxine Sodium62$729
Gabapentin40$711
Rosuvastatin Calcium40$601
Atorvastatin Calcium60$595
Cyclobenzaprine Hcl47$544
Escitalopram Oxalate18$476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$450$47,69836 claims
Novo NordiskOzempic$409$23,65913 claims
Boehringer IngelheimJardiance$68$22,37815 claims
PfizerPaxlovid$163$1,42917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 928 family medicine providers in Utah.

Other family medicine in Draper

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →